1. Home
  2. Directory
  3. Texas
  4. Bellaire
  5. Ophthalmology
  6. NPI Profile
  7. Prescriptions 1942591839

OTIS BENNETT WALTON IV MD
Prescription History 1942591839
Ophthalmology in Bellaire, TX


Quality Rating: 100 out of 100 score

NPI Status: Active since April 26, 2011

Contact Information

6800 WEST LOOP SOUTH
STE 400/450
BELLAIRE, TX
ZIP 77401
Phone: (281) 944-8020
Fax: (281) 849-7505

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for OTIS BENNETT WALTON IV MD, an active Ophthalmology specialist practicing in Bellaire, TX. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 330 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 114 claims alone.

Medication Index

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 24
30-Day Fills 42.1
Days Supply 1,228
TX State Average Benchmarks
Peer Average Claims161.0
Peer Average 30-Day Fills298.3
Peer Average Days Supply8,546
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.1% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $482.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.10

State Avg Cost Per Claim

$25.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 42
30-Day Fills 42.0
Days Supply 455
TX State Average Benchmarks
Peer Average Claims101.0
Peer Average 30-Day Fills102.9
Peer Average Days Supply1,617
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.4% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,260.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.01

State Avg Cost Per Claim

$36.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Ofloxacin

Generic Formulation: OfloxacinSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 69
30-Day Fills 70.1
Days Supply 1,076
TX State Average Benchmarks
Peer Average Claims68.0
Peer Average 30-Day Fills72.5
Peer Average Days Supply1,492
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,110.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.10

State Avg Cost Per Claim

$24.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.

Therapeutic Applications

This medication is used to treat eye infections. Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Polymyxin B Sul-Trimethoprim

Generic Formulation: Polymyxin B Sulf/TrimethoprimSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 13
30-Day Fills 16.5
Days Supply 436
TX State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills65.6
Peer Average Days Supply1,788
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 72.3% less volume than the regional standard for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $138.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.62

State Avg Cost Per Claim

$8.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye. It contains 2 antibiotics. Polymyxin B works by killing the bacteria. Trimethoprim works by stopping the growth of the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 114
30-Day Fills 128.2
Days Supply 3,448
TX State Average Benchmarks
Peer Average Claims130.0
Peer Average 30-Day Fills168.2
Peer Average Days Supply4,409
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,802.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$50.90

State Avg Cost Per Claim

$51.46

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Prolensa

Generic Formulation: Bromfenac SodiumSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 68
30-Day Fills 82.6
Days Supply 2,313
TX State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills79.8
Peer Average Days Supply2,211
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $24,317.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$357.61

State Avg Cost Per Claim

$342.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like OTIS BENNETT WALTON IV MD provides transparency into local medical care patterns within Bellaire, TX.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Ophthalmology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.